Cancer Science Institute of Singapore, National University of Singapore, Singapore; Department of Haematology-Oncology, National University Cancer Institute of Singapore, Singapore; School of Surgery, University of Western Australia, Perth, Australia.
Department of Thoracic Medicine, St. Vincent's Hospital, Kinghorn Cancer Centre, Sydney, Australia.
J Thorac Oncol. 2017 Aug;12(8):1183-1209. doi: 10.1016/j.jtho.2017.05.019. Epub 2017 Jun 1.
Lung cancer care is rapidly changing with advances in genomic testing, the development of next-generation targeted kinase inhibitors, and the continued broad study of immunotherapy in new settings and potential combinations. The International Association for the Study of Lung Cancer and the Journal of Thoracic Oncology publish this annual update to help readers keep pace with these important developments. Experts in thoracic cancer and care provide focused updates across multiple areas, including prevention and early detection, molecular diagnostics, pathology and staging, surgery, adjuvant therapy, radiotherapy, molecular targeted therapy, and immunotherapy for NSCLC, SCLC, and mesothelioma. Quality and value of care and perspectives on the future of lung cancer research and treatment have also been included in this concise review.
肺癌的治疗方法在不断发展，包括基因组检测的进步、下一代靶向激酶抑制剂的开发，以及免疫疗法在新环境和潜在联合治疗中的广泛研究。国际肺癌研究协会和《胸部肿瘤学杂志》发表了这一年度更新，以帮助读者跟上这些重要进展。胸部癌症和护理方面的专家提供了多个领域的重点更新，包括预防和早期发现、分子诊断、病理和分期、手术、辅助治疗、放疗、非小细胞肺癌、小细胞肺癌和间皮瘤的分子靶向治疗，以及免疫治疗。本简明综述还包括对肺癌研究和治疗未来的质量和价值的看法。
